Coronary thrombolysis with intracoronary streptokinase. 1987

P A Ludbrook, and P Rentrop

Because there are several means by which a clinician may pharmacologically activate the fibrinolytic system for thrombolysis, the clinician must understand the clinical ramifications of the use of each pharmacologic agent. Intracoronary streptokinase is one such agent whose therapeutic use, although effective in many cases, must not be taken lightly. This article, therefore, reviews the pharmacology, therapeutic uses, and possible complications that could arise as a result of intracoronary streptokinase.

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013300 Streptokinase Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-. Avelizin,Awelysin,Celiase,Distreptase,Kabikinase,Kabivitrum,Streptase,Streptodecase

Related Publications

P A Ludbrook, and P Rentrop
July 1983, Annals of emergency medicine,
P A Ludbrook, and P Rentrop
April 1984, The Journal of thoracic and cardiovascular surgery,
P A Ludbrook, and P Rentrop
January 1986, Catheterization and cardiovascular diagnosis,
P A Ludbrook, and P Rentrop
June 1985, Texas Heart Institute journal,
P A Ludbrook, and P Rentrop
February 1982, The New England journal of medicine,
P A Ludbrook, and P Rentrop
October 1987, Journal of cardiothoracic anesthesia,
P A Ludbrook, and P Rentrop
February 1987, Cardiology clinics,
P A Ludbrook, and P Rentrop
January 1982, Journal of emergency nursing,
Copied contents to your clipboard!